Phage Display Reveals VLRB-Mediated Recognition of Minimal Tumor Glycan Antigen Sialyl-Tn
Authors:
Open Access
- 26 September 2025
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (10) , 802
Abstract
Sialyl-Tn (sTn) is a tumor-associated carbohydrate antigen (TACA) abundantly expressed by various types of carcinomas. While conventional antibody-based platforms have traditionally been used for the detection and targeting of sTn, alternative binding scaffolds may offer distinct advantages. Variable lymphocyte receptor B (VLRB), the immunoglobulin-like molecule of jawless vertebrates, offers a promising alternative for glycan recognition. In this study, a phage-displayed VLRB library was utilized to identify sTn-specific binders. Two candidates, designated as ccombodies A8 and B11, were isolated after four rounds of biopanning. Both were expressed and purified using Ni-affinity and FPLC, yielding proteins with apparent molecular weights of ~27 kDa in SDS-PAGE. Sequence analysis revealed a preference for glycan-binding residues in randomized hypervariable regions, with A8 exhibiting an increased aliphatic content. ELISA confirmed selective binding to sTn and other O-glycans containing the core α-GalNAc, with EC50 values of 18.2 and 14.2 nM for A8 and B11, respectively. Vicia villosa lectin inhibited ccombody binding to sTn, indicating shared epitope recognition. Additionally, both ccombodies bound to sTn-positive glycoproteins and carcinoma cell lines HeLa and LS174T. These findings demonstrate that phage display of VLRBs enables the identification of high-affinity, glycan-specific binders, offering a compelling alternative to immunoglobulin-based platforms for future diagnostic and therapeutic applications targeting tumor-associated glycans.Keywords
Funding Information
- National Research Foundation of Korea (RS-2023-00235511, R1A2B5B02002220)
This publication has 73 references indexed in Scilit:
- Tumor-associated carbohydrate antigens of MUC1 – Implication in cancer developmentBiomedicine & Pharmacotherapy, 2024
- Generation of glycan-specific nanobodiesCell Chemical Biology, 2022
- Identification of Glycan-Specific Variable Lymphocyte Receptors Using Yeast Surface Display and Glycan Microarrays2021
- Lamprey Variable Lymphocyte Receptor Monoclonal Antibodies for Whole-Cell Surface Antigens2021
- High-affinity anti-glycan antibodies: challenges and strategiesCurrent Opinion in Immunology, 2019
- Isolation of Antibodies to Heparan Sulfate on Glypicans by Phage DisplayCurrent Protocols in Protein Science, 2018
- Aberrant Glycosylation in Cancer: A Novel Molecular Mechanism Controlling MetastasisCancer Cell, 2017
- Yeast Surface Display of Lamprey Variable Lymphocyte Receptors2011
- Mucins in the pathogenesis of breast cancer: Implications in diagnosis, prognosis and therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2011
- Characterisation of the tumour-associated carbohydrate epitope recognised by monoclonal antibody 4D3International Journal of Cancer, 1996